Xvivo Perfusion
180.10 SEK
-1.80 %
Less than 1K followers
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xvivo Perfusion
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 220.8 | 179.9 | 258.4 | 415.3 | 597.5 | 822.4 | 812.2 |
| growth-% | -18.6 % | 43.7 % | 60.7 % | 43.9 % | 37.6 % | -1.2 % | |
| EBITDA | 28.8 | -15.6 | 13.8 | 48.6 | 80.5 | 176.1 | 158.6 |
| EBIT | 3.9 | -45.7 | -18.5 | 6.4 | 4.2 | 88.4 | 88.4 |
| Profit before taxes | 5.3 | -57.3 | 6.7 | 22.3 | 94.5 | 200.0 | 38.6 |
| Net income | 4.9 | -43.7 | 8.2 | 18.4 | 91.8 | 172.2 | 25.2 |
| EPS | 0.19 | -1.62 | 0.28 | 0.62 | 3.07 | 5.47 | 0.80 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 0.0 % | -0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 13.0 % | -8.7 % | 5.3 % | 11.7 % | 13.5 % | 21.4 % | 19.5 % |
| EBIT-% | 1.8 % | -25.4 % | -7.2 % | 1.5 % | 0.7 % | 10.7 % | 10.9 % |
| ROE | 0.9 % | -4.3 % | 0.6 % | 1.3 % | 4.7 % | 8.0 % | 1.2 % |
| ROI | 0.8 % | -3.8 % | 0.5 % | 1.1 % | 4.2 % | 7.2 % | 1.1 % |